March Altus Capital Management’s Biogen BIIB Stock Holding History

March Altus Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$814K	Buy	+2,600	New	+$770K	5.09%	9
2014 Q4	–	Sell	-32,986	Closed	-$10.9M	–	24
2014 Q3	$10.9M	Buy	32,986 +7,825	+31%	+$2.58M	4.34%	10
2014 Q2	$7.93M	Sell	25,161 -11,815	-32%	-$3.56M	2.91%	18
2014 Q1	$11.3M	Buy	+36,976	New	+$11.7M	3.63%	11

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

March Altus Capital Management's BIIB Position: Q3 2016 in Review

March Altus Capital Management opened a new position in Biogen (BIIB) in Q3 2016: 2,600 shares worth $814K. The stake represents 5.09% of the portfolio and ranks #9 among its holdings. This is a return to the name: March Altus Capital Management previously reported a position in BIIB as recently as Q3 2014.

March Altus Capital Management first reported a position in BIIB in Q1 2014 and has held it in 4 quarters since. The position peaked at $11.3M in Q1 2014. 1,013 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

March Altus Capital Management held 2,600 shares of Biogen worth $814K as of Q3 2016.
Biogen was a new March Altus Capital Management position in Q3 2016.
Biogen made up 5.09% of March Altus Capital Management's portfolio in Q3 2016, its #9 holding.
March Altus Capital Management first reported a position in Biogen in Q1 2014 and has held it in 4 quarters since.
March Altus Capital Management's Biogen position peaked at $11.3M in Q1 2014.
1,013 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on March Altus Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.